This is the authors' abstract. We don't add key points for this paper.
Twenty-one patients with chronic plaque psoriasis were treated with bath 8-methoxypsoralen (8-MOP) and ultraviolet A (UVA). Clearing was achieved in sixty per cent of patients which was less than would be expected with oral 8-MOP. The treatment was well tolerated and was preferred by those who had previously been treated with oral psoralen. The cumulative dose of UVA was only one-fifth that expected with oral 8-MOP.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Collins et al. (1991) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: